Notice for trientine hydrochloride (Reach Pharmaceuticals Pty Ltd)
Active ingredients
trientine hydrochloride
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Capsule
Indication
For the treatment of Wilson's Disease
Therapeutic area
Inherited metabolic disorders